(5Z)-5-[(1,3-benzodioxo-5-yl)methylene]-3-methyl-2-[2-{(2,3-dihydrobezofuran-5-yl)methylamino}ethylamino]-3,5-dihydro-4H-imidazol-4-one

ID: ALA1081218

Chembl Id: CHEMBL1081218

PubChem CID: 135860195

Max Phase: Preclinical

Molecular Formula: C23H24N4O4

Molecular Weight: 420.47

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1NCCNCc1ccc2c(c1)OCC2

Standard InChI:  InChI=1S/C23H24N4O4/c1-27-22(28)18(10-15-3-5-19-21(11-15)31-14-30-19)26-23(27)25-8-7-24-13-16-2-4-17-6-9-29-20(17)12-16/h2-5,10-12,24H,6-9,13-14H2,1H3,(H,25,26)/b18-10-

Standard InChI Key:  FTFATIYAGQBZNZ-ZDLGFXPLSA-N

Alternative Forms

  1. Parent:

    ALA1081218

    ---

Associated Targets(Human)

CSNK2B Tbio Casein kinase I isoform alpha/subunit beta (18 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK5 Tchem Cyclin-dependent kinase 5/CDK5 activator 1 (3697 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSK3A Tclin Glycogen synthase kinase-3 (736 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 420.47Molecular Weight (Monoisotopic): 420.1798AlogP: 1.90#Rotatable Bonds: 6
Polar Surface Area: 84.42Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.54CX LogP: 2.11CX LogD: 1.74
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.55Np Likeness Score: -0.46

References

1. Debdab M, Renault S, Lozach O, Meijer L, Paquin L, Carreaux F, Bazureau JP..  (2010)  Synthesis and preliminary biological evaluation of new derivatives of the marine alkaloid leucettamine B as kinase inhibitors.,  45  (2): [PMID:19879673] [10.1016/j.ejmech.2009.10.009]

Source